Wandercraft raises $75m in funding to introduce self-balancing exoskeleton
Wandercraft has raised $75m in a Series D funding round to introduce the self-balancing personal exoskeleton, Eve, to market by 2026. The post Wandercraft raises $75m in funding to introduce self-balancing exoskeleton appeared first on Medical Device Network.
Wandercraft has raised $75m in a Series D funding round to introduce the self-balancing personal exoskeleton, Eve, to market by 2026.
The post Wandercraft raises $75m in funding to introduce self-balancing exoskeleton appeared first on Medical Device Network.
